• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by United Parks & Resorts Inc.

    8/8/25 4:08:17 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $PRKS alert in real time by email
    S-8 POS 1 prks-s-8_2025_omnibus.htm S-8 POS S-8 POS

     

    As filed with the Securities and Exchange Commission on August 8, 2025.

    Registration No. 333-188010

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    POST-EFFECTIVE AMENDMENT NO. 2 TO

    FORM S-8

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

    United Parks & Resorts Inc.

    (Exact name of registrant as specified in its charter)

    Delaware

    27-1220297

    (State or other jurisdiction of

    incorporation or organization)

    (I.R.S. Employer

    Identification No.)

    6240 Sea Harbor Drive

    Orlando, Florida 32821

    Telephone: (407) 226-5011

    (Address, including zip code, and telephone number, including area code, of principal executive offices)

    United Parks & Resorts Inc. 2017 Omnibus Incentive Plan

    United Parks & Resorts Inc. 2025 Omnibus Incentive Plan

    (Full title of the plans)

    G. Anthony (Tony) Taylor, Esq.

    Chief Legal Officer, General Counsel and Corporate Secretary

    6240 Sea Harbor Drive

    Orlando, Florida 32819

    Telephone: (407) 226-5011

    (Name and address, including zip code, and telephone number, including area code, of agent for service)

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

    Large accelerated filer

    ☒

    Accelerated filer

    ☐

    Non-accelerated filer

    ☐

    Smaller reporting company

    ☐

     

     

    Emerging growth company

    ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     


     

    EXPLANATORY NOTE

    On April 19, 2013, United Parks & Resorts Inc. (f/k/a SeaWorld Entertainment, Inc.) (the “Company” or the “Registrant”) filed a registration statement on Form S-8 (Registration No. 333-188010) (the “Registration Statement”) with the Securities and Exchange Commission (the “Commission”) to register 15,000,000 shares of the Company’s Common Stock (“Common Stock”) available for issuance under the SeaWorld Entertainment, Inc. 2013 Omnibus Incentive Plan (the “2013 Incentive Plan”). The Registration Statement also covered an indeterminate number of shares of Common Stock as may have become issuable as a result of stock dividends, stock splits, reverse stock splits, recapitalizations, reclassifications, mergers, split-ups, reorganizations, consolidations and other capital adjustments. The Company paid a registration fee of $55,242 at that time to register the securities.

    On June 28, 2017, the Company amended the Registration Statement by filing a post-effective amendment to the Registration Statement with the Commission (“Post-Effective Amendment No. 1”) to reflect that the 2013 Incentive Plan was being replaced by the SeaWorld Entertainment, Inc. 2017 Omnibus Incentive Plan (the “2017 Incentive Plan”). Post-Effective Amendment No. 1 reflected that 7,079,237 shares of Common Stock, which were previously available for issuance under the 2013 Incentive Plan, became available for issuance under the 2017 Incentive Plan, plus the number of shares of Common Stock underlying any award granted under the 2013 Incentive Plan that expired, terminated or was canceled or forfeited for any reason whatsoever under the terms of the 2013 Incentive Plan.

    On June 13, 2025 (the “Approval Date”), the stockholders of the Company approved the United Parks & Resorts Inc. 2025 Omnibus Incentive Plan (the “2025 Incentive Plan”). As of the Approval Date, no new awards may be granted under the 2017 Incentive Plan (although awards made under the 2017 Incentive Plan prior to the Approval Date will remain outstanding in accordance with their terms and those of the 2017 Incentive Plan). The number of shares of Common Stock for which awards may be granted under the 2025 Incentive Plan is 6,320,680 shares of Common Stock, which were previously available for issuance under the 2017 Incentive Plan and, pursuant to the terms of the 2025 Incentive Plan, have become available for issuance under the 2025 Incentive Plan, plus the number of shares of Common Stock underlying any award granted under the 2017 Incentive Plan that expires, terminates or is canceled or forfeited for any reason whatsoever under the terms of the 2017 Incentive Plan (collectively, the “Carryover Shares”).

    Accordingly, pursuant to the undertaking in Item 512(a)(1)(iii) of Regulation S-K that the Company disclose a material change in the plan of distribution as it was originally disclosed in the Registration Statement, the Company is filing this Post-Effective Amendment No. 2 to the Registration Statement (“Post- Effective Amendment No. 2”) to reflect that, as of the Approval Date, the Carryover Shares may be issued under the 2025 Incentive Plan and to file as an exhibit hereto a copy of the 2025 Incentive Plan and a new opinion as to the validity of the shares of Common Stock that were previously issuable pursuant to the 2017 Incentive Plan. This Post-Effective Amendment No. 2 to the Registration Statement amends and supplements the items listed below. All other items of the Registration Statement are incorporated herein by reference without change (the Registration Statement as amended by Post-Effective Amendment No. 1 and Post- Effective Amendment No. 2, the “Amended Registration Statement”).

     


     

    Part I


    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

    The information specified in Items 1 and 2 of Part I of the Form S-8 is omitted from this filing in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”), and the introductory note to Part I of the Form S-8.

    The documents containing the information specified in this Part I will be delivered to the participants in the 2025 Incentive Plan covered by this Amended Registration Statement as required by Rule 428(b)(1). Such documents are not required to be filed with the Commission as part of this Amended Registration Statement.

    Part II


    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3. Incorporation of Documents by Reference.

    The following documents filed with the Commission by the Company pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended the (“Exchange Act”), are hereby incorporated by reference in this Amended Registration Statement:

    (1)
    The Registrant’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Commission on March 3, 2025;
    (2)
    The Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the Commission on May 12, 2025;
    (3)
    The Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, filed with the Commission on August 8, 2025;
    (4)
    The Registrant’s Current Reports on Form 8-K, filed with the Commission on June 17, 2025 and July 22, 2025; and
    (5)
    Description of the Registrant’s Securities (incorporated by reference to Exhibit 4.1 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2020).

    All documents that the Company subsequently files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Amended Registration Statement (except for any portions of the Company’s Current Reports on Form 8-K furnished pursuant to Item 2.02 or Item 7.01 thereof and any corresponding exhibits thereto not filed with Commission), and prior to the filing of a post-effective amendment to this Amended Registration Statement indicating that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Amended Registration Statement and to be a part hereof from the date of filing of such documents.

    Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Amended Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Amended Registration Statement.

    Item 4. Description of Securities.

    Not applicable.

    2


     

    Item 5. Interests of Named Experts and Counsel.

    Not applicable.

    Item 6. Indemnification of Directors and Officers.

    Section 102(b)(7) of the Delaware General Corporation Law (the “DGCL”) allows a corporation to provide in its certificate of incorporation that a director of the corporation will not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except where the director breached the duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit. The Company’s Amended and Restated Certificate of Incorporation provides for this limitation of liability.

    Section 145 of the DGCL (“Section 145”) provides, among other things, that a Delaware corporation may indemnify any person who was, is or is threatened to be made, party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person is or was an officer, director, employee or agent of such corporation or is or was serving at the request of such corporation as a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation’s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was unlawful. A Delaware corporation may indemnify any persons who were or are a party to any threatened, pending or completed action or suit by or in the right of the corporation by reason of the fact that such person is or was a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit, provided such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation’s best interests, provided further that no indemnification is permitted without judicial approval if the officer, director, employee or agent is adjudged to be liable to the corporation. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against the expenses (including attorneys’ fees) which such officer or director has actually and reasonably incurred.

    Section 145 further authorizes a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation or enterprise, against any liability asserted against such person and incurred by such person in any such capacity, or arising out of his or her status as such, whether or not the corporation would otherwise have the power to indemnify such person under Section 145.

    The Company’s Amended and Restated Bylaws provide that the Company must indemnify and advance expenses to its directors and officers to the full extent authorized by the DGCL.

    The indemnification rights set forth above shall not be exclusive of any other right which an indemnified person may have or hereafter acquires under any statute, any provision of the Company’s Amended and Restated Certificate of Incorporation, its Amended and Restated Bylaws, agreement, vote of stockholders or disinterested directors or otherwise. Notwithstanding the foregoing, the Company shall not be obligated to indemnify a director or officer in respect of a proceeding (or part thereof) instituted by such director or officer, unless such proceeding (or part thereof) has been authorized by the Company’s Board of Directors pursuant to the applicable procedure outlined in the Amended and Restated Bylaws.

    Section 174 of the DGCL provides, among other things, that a director, who willfully or negligently approves of an unlawful payment of dividends or an unlawful stock purchase or redemption, may be held jointly and severally liable for such actions. A director who was either absent when the unlawful actions were approved or dissented at the time may avoid liability by causing his or her dissent to such actions to be entered in the books containing the minutes of

    3


     

    the meetings of the Board of Directors at the time such action occurred or immediately after such absent director receives notice of the unlawful acts.

    The Company expects to maintain standard policies of insurance that provide coverage (1) to its directors and officers against loss rising from claims made by reason of breach of duty or other wrongful act and (2) to the Company with respect to indemnification payments that it may make to such directors and officers.

    Item 7 Exemption from Registration Claimed.

    Not applicable.

    Item 8. Exhibits.

    For a list of exhibits, see the Exhibit Index in this Amended Registration Statement, which is incorporated herein by reference.

    Item 9. Undertakings.

    (a)
    The undersigned registrant hereby undertakes:
    (1)
    To file, during any period in which offers or sales are being made, a post-effective amendment to this Amended Registration Statement:
    (i)
    To include any prospectus required by Section 10(a)(3) of the Securities Act.
    (ii)
    To reflect in the prospectus any facts or events arising after the effective date of the Amended Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Amended Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement.
    (iii)
    To include any material information with respect to the plan of distribution not previously disclosed in the Amended Registration Statement or any material change to such information in the Amended Registration Statement;

    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the registration statement is on Form S-8, and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference in the Amended Registration Statement.

    (2)
    That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
    (3)
    To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

    4


     

    (b)
    The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Amended Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
    (c)
    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

    5


     

    SIGNATURES

    Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Orlando, Florida, on August 8, 2025.

    UNITED PARKS & RESORTS INC.

    By: /s/ MARC G. SWANSON

    Name: Marc G. Swanson
    Title: Chief Executive Officer

    POWER OF ATTORNEY

    KNOW ALL MEN BY THESE PRESENTS: that the undersigned directors and officers of United Parks & Resorts Inc. hereby constitute and appoint G. Anthony (Tony) Taylor and Marc G. Swanson and each of them, any of whom may act without joinder of the other, the individual’s true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the person and in his or her name, place and stead, in any and all capacities, to sign this Registration Statement and any or all amendments, including post-effective amendments to the Registration Statement, including a prospectus or an amended prospectus therein and any Registration Statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act, and all other documents in connection therewith to be filed with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact as agents or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement and power of attorney have been signed by the following persons in the capacities indicated on August 8, 2025.

    Signature

    Title

     /s/ MARC G. SWANSON

     Marc G. Swanson

    Chief Executive Officer
    (Principal Executive Officer)

     /s/ JAMES MIKOLAICHIK

     James Mikolaichik

    Chief Financial Officer
    (Principal Financial Officer)

     /s/ BILL MYERS

     Bill Myers

    Chief Accounting Officer
    (Principal Accounting Officer)

     /s/ JAMES CHAMBERS

     James Chambers

    Director

     /s/ AAYUSHI DALAL

     Aayushi Dalal

    Director

     


     

     

     

     /s/ WILLIAM GRAY

     William Gray

     

    Director

     /s/ TIMOTHY J. HARTNETT

     Timothy J. Hartnett

    Director

     /s/ NATHANIEL J. LIPMAN

     Nathaniel J. Lipman

    Director

     /s/ YOSHIKAZU MARUYAMA

     Yoshikazu Maruyama

    Director

     /s/ THOMAS E. MOLONEY

     Thomas E. Moloney

    Director

     /s/ NEHA JOGANI NARANG

     Neha Jogani Narang

    Director

     /s/ SCOTT I. ROSS

     Scott I. Ross

    Director

     /s/ KIMBERLY K. SCHAEFER

     Kimberly K. Schaefer

    Director

     

     


     

    INDEX OF EXHIBITS

    Exhibit Number

    Description of Document

    4.1

    Amended and Restated Certificate of Incorporation of United Parks & Resorts Inc. (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on April 24, 2013 (File No. 001-35883)).

    4.2

    Certificate of Amendment of Amended and Restated Certificate of Incorporation of United Parks & Resorts Inc., effective June 15, 2016 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on June 17, 2016 (File No. 001-35883)).

    4.3

    Certificate of Amendment of Amended and Restated Certificate of Incorporation of United Parks & Resorts Inc., effective February 12, 2024 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on February 12, 2024 (File No. 001-35883)).

    4.4

    Amended and Restated Bylaws of United Parks & Resorts Inc. (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed on February 12, 2024 (File No. 001-35883)).

    4.5†

    United Parks & Resorts Inc. 2025 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 17, 2025 (File No. 001-35883)).

    5.1*

    Opinion of Simpson Thacher & Bartlett LLP.

    23.1*

    Consent of KPMG LLP.

    23.2*

    Consent of Deloitte & Touche LLP.

    23.3*

    Consent of Simpson Thacher & Bartlett LLP (included as part of Exhibit 5.1).

    24.1*

    Power of Attorney (included in the signature pages to this Registration Statement).

     

    * Filed herewith

    † Management or compensatory arrangement

     

     


    Get the next $PRKS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PRKS

    DatePrice TargetRatingAnalyst
    3/14/2025$50.00Equal Weight
    Barclays
    8/8/2024$63.00 → $53.00Buy → Neutral
    Goldman
    4/4/2024$73.00Buy
    Guggenheim
    3/26/2024$47.00Underperform
    Mizuho
    More analyst ratings

    $PRKS
    SEC Filings

    View All

    SEC Form PRE 14A filed by United Parks & Resorts Inc.

    PRE 14A - United Parks & Resorts Inc. (0001564902) (Filer)

    8/8/25 5:15:41 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form S-8 POS filed by United Parks & Resorts Inc.

    S-8 POS - United Parks & Resorts Inc. (0001564902) (Filer)

    8/8/25 4:08:17 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 10-Q filed by United Parks & Resorts Inc.

    10-Q - United Parks & Resorts Inc. (0001564902) (Filer)

    8/8/25 7:15:05 AM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $PRKS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on United Parks & Resorts Inc. with a new price target

    Barclays initiated coverage of United Parks & Resorts Inc. with a rating of Equal Weight and set a new price target of $50.00

    3/14/25 7:39:46 AM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    United Parks & Resorts Inc. downgraded by Goldman with a new price target

    Goldman downgraded United Parks & Resorts Inc. from Buy to Neutral and set a new price target of $53.00 from $63.00 previously

    8/8/24 6:48:33 AM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Guggenheim initiated coverage on United Parks & Resorts Inc. with a new price target

    Guggenheim initiated coverage of United Parks & Resorts Inc. with a rating of Buy and set a new price target of $73.00

    4/4/24 8:11:55 AM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $PRKS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Mikolaichik James bought $1,947,860 worth of shares (34,000 units at $57.29), increasing direct ownership by 80% to 76,267 units (SEC Form 4)

    4 - United Parks & Resorts Inc. (0001564902) (Issuer)

    11/25/24 4:10:18 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $PRKS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Moloney Thomas E was granted 617 shares, increasing direct ownership by 0.77% to 80,995 units (SEC Form 4)

    4 - United Parks & Resorts Inc. (0001564902) (Issuer)

    8/13/25 8:13:23 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Maruyama Yoshikazu was granted 617 shares, increasing direct ownership by 1% to 47,741 units (SEC Form 4)

    4 - United Parks & Resorts Inc. (0001564902) (Issuer)

    8/13/25 8:13:03 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Hartnett Timothy was granted 617 shares, increasing direct ownership by 0.94% to 66,425 units (SEC Form 4)

    4 - United Parks & Resorts Inc. (0001564902) (Issuer)

    8/13/25 8:12:43 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $PRKS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    United Parks & Resorts Inc. Reports Second Quarter and First Six Months 2025 Results

    ORLANDO, Fla., Aug. 7, 2025 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE:PRKS), a leading theme park and entertainment company, today reported its financial results for the second quarter and first six months of fiscal year 2025. Second Quarter 2025 Highlights Attendance was 6.2 million guests, an increase of approximately 48 thousand guests or 0.8% from the second quarter of 2024.Total revenue was $490.2 million, a decrease of $7.4 million or 1.5% from the second quarter of 2024.Net income was $80.1 million, a decrease of $11.0 million or 12.1% from the second quarter of 2024.Adjusted EBITDA[1] was $206.3 million, a decrease of $11.9 million or 5.4% from the second quarter of 2024.Tota

    8/7/25 6:30:00 AM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    UNITED PARKS & RESORTS INC. ANNOUNCES SECOND QUARTER EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

    ORLANDO, Fla., July 14, 2025 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE: PRKS) announced today that it will release its second quarter financial results before the market opens on Thursday, August 7, 2025. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Thursday, August 7, 2025, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.UnitedParksInvestors.com. For those unable to participate in the live webcast, a replay will be available b

    7/14/25 5:00:00 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    In Celebration of July 4th, Busch Gardens is Proud to Honor Veterans and Active-Duty Military with FREE Tickets as a Thank You for their Service

    Active-duty military and Veterans plus their guests are invited to visit the parks for FREE ORLANDO, Fla., June 13, 2025 /PRNewswire/ -- In advance of Independence Day, Busch Gardens parks in Tampa Bay and Williamsburg as well as Adventure Island and Water Country USA are proudly honoring the bravery and sacrifice of all U.S. military active-duty and veterans and their families to enjoy a day at the parks for FREE. It's Busch Gardens' way of saying thank you – and giving America's heroes the chance to create unforgettable memories with the people they love. U.S. military veter

    6/13/25 12:43:00 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $PRKS
    Leadership Updates

    Live Leadership Updates

    View All

    The Legacy Continues: North America's Longest Inverted Family Coaster Opens at Busch Gardens Williamsburg on May 23 with the Return of the Big Bad Wolf

    Members will be among the first to ride beginning May 16 during the park's monumental 50thAnniversary Celebration festivities, including a special lookback presentation, 1970s music, fireworks and more DOWNLOAD MEDIA ASSETS HERE WILLIAMSBURG, Va., May 1, 2025 /PRNewswire/ -- Hear the howl as The Big Bad Wolf: The Wolf's Revenge, Busch Gardens Williamsburg's newest and most immersive family attraction is unleashed on May 23 as North America's longest family inverted coaster. Members will be among the first to ride starting on May 16 during the park's 50th anniversary celebration. Members will also get additional exclusive ride times on May 17 and 18.

    5/1/25 1:00:00 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SeaWorld Orlando Reaches Historic Milestone with 1,000th Manatee Rescue, Reinforcing Decades of Dedication to Animal Rescue, Rehabilitation and Return

    DOWNLOAD MEDIA ASSETS HERE ORLANDO, Fla., March 26, 2025 /PRNewswire/ -- SeaWorld Orlando has reached a historic milestone – 1,000 manatee rescues – marking a significant step in the ongoing fight to protect this vulnerable species. This achievement highlights SeaWorld's leadership in marine conservation, reinforcing its critical role in rescue, rehabilitation and return efforts. SeaWorld Orlando has spent nearly five decades committed to marine wildlife conservation and rescue. Since 1976, SeaWorld Orlando's dedicated rescue team has operated one of only three critical care f

    3/26/25 8:00:00 AM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Five Manatees Successfully Rehabilitated at Two Ohio Zoos Flown Back to Florida Facilities to Prepare for Return to Home Waters

    ORLANDO, Fla., Oct. 15, 2024 /PRNewswire/ -- Five manatees were flown more than 1,000 miles to their temporary homes in Florida, marking a crucial conservation achievement following over two years of successful rescue efforts by four zoological and marine institutions. In an intricate operation, the manatees were placed in custom-built containers to help them travel safely and then driven to the Cincinnati International Airport at the DHL Express Global hub. All of the manatees were loaded onto a specially scheduled DHL cargo plane to head to Florida, where they will complete

    10/15/24 10:00:00 AM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $PRKS
    Financials

    Live finance-specific insights

    View All

    United Parks & Resorts Inc. Reports Second Quarter and First Six Months 2025 Results

    ORLANDO, Fla., Aug. 7, 2025 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE:PRKS), a leading theme park and entertainment company, today reported its financial results for the second quarter and first six months of fiscal year 2025. Second Quarter 2025 Highlights Attendance was 6.2 million guests, an increase of approximately 48 thousand guests or 0.8% from the second quarter of 2024.Total revenue was $490.2 million, a decrease of $7.4 million or 1.5% from the second quarter of 2024.Net income was $80.1 million, a decrease of $11.0 million or 12.1% from the second quarter of 2024.Adjusted EBITDA[1] was $206.3 million, a decrease of $11.9 million or 5.4% from the second quarter of 2024.Tota

    8/7/25 6:30:00 AM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    UNITED PARKS & RESORTS INC. ANNOUNCES SECOND QUARTER EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

    ORLANDO, Fla., July 14, 2025 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE: PRKS) announced today that it will release its second quarter financial results before the market opens on Thursday, August 7, 2025. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Thursday, August 7, 2025, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.UnitedParksInvestors.com. For those unable to participate in the live webcast, a replay will be available b

    7/14/25 5:00:00 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    United Parks & Resorts Inc. Reports First Quarter 2025 Results

    ORLANDO, Fla., May 12, 2025 /PRNewswire/ -- United Parks & Resorts Inc. (NYSE:PRKS), a leading theme park and entertainment company, today reported its financial results for the first quarter of 2025. First Quarter 2025 Highlights Attendance was 3.4 million guests, a decrease of approximately 59,000 guests or 1.7% from the first quarter of 2024.Total revenue was $286.9 million, a decrease of $10.5 million or 3.5% from the first quarter of 2024.Net loss was $16.1 million, a decrease of $4.9 million from the first quarter of 2024.Adjusted EBITDA[1] was $67.4 million, a decrease

    5/12/25 6:30:00 AM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $PRKS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by United Parks & Resorts Inc.

    SC 13D/A - United Parks & Resorts Inc. (0001564902) (Subject)

    11/13/24 5:20:01 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by United Parks & Resorts Inc.

    SC 13G - United Parks & Resorts Inc. (0001564902) (Subject)

    11/13/24 4:16:58 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by United Parks & Resorts Inc.

    SC 13D/A - United Parks & Resorts Inc. (0001564902) (Subject)

    8/12/24 7:01:08 PM ET
    $PRKS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care